Claret Asset Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $980K | Sell |
10,839
-6
| -0.1% | -$551 | 0.12% | 80 |
|
|
2025
Q4 | $975K | Sell |
10,845
-101
| -0.9% | -$9.58K | 0.11% | 85 |
|
|
2025
Q3 | $1.08M | Sell |
10,946
-772
| -7% | -$76.5K | 0.13% | 81 |
|
|
2025
Q2 | $1.07M | Buy |
11,718
+642
| +6% | +$62.1K | 0.14% | 76 |
|
|
2025
Q1 | $1.25M | Sell |
11,076
-431
| -4% | -$46.1K | 0.18% | 70 |
|
|
2024
Q4 | $1.22M | Buy |
11,507
+13
| +0.1% | +$1.4K | 0.19% | 63 |
|
|
2024
Q3 | $1.24M | Sell |
11,494
-270
| -2% | -$29.5K | 0.2% | 60 |
|
|
2024
Q2 | $1.28M | Buy |
11,764
+734
| +7% | +$86.5K | 0.23% | 57 |
|
|
2024
Q1 | $1.46M | Sell |
11,030
-82
| -0.7% | -$10.2K | 0.24% | 57 |
|
|
2023
Q4 | $1.35M | Sell |
11,112
-147
| -1% | -$16.4K | 0.24% | 58 |
|
|
2023
Q3 | $1.26M | Sell |
11,259
-27
| -0.2% | -$3.43K | 0.25% | 58 |
|
|
2023
Q2 | $1.64M | Sell |
11,286
-270
| -2% | -$36.7K | 0.32% | 52 |
|
|
2023
Q1 | $1.49M | Sell |
11,556
-117
| -1% | -$14.7K | 0.29% | 55 |
|
|
2022
Q4 | $1.49M | Sell |
11,673
-13
| -0.1% | -$1.51K | 0.33% | 52 |
|
|
2022
Q3 | $1.22M | Sell |
11,686
-22
| -0.2% | -$2.41K | 0.29% | 56 |
|
|
2022
Q2 | $1.23M | Buy |
11,708
+196
| +2% | +$23.3K | 0.27% | 57 |
|
|
2022
Q1 | $1.47M | Sell |
11,512
-392
| -3% | -$47.3K | 0.28% | 56 |
|
|
2021
Q4 | $1.47M | Sell |
11,904
-31
| -0.3% | -$4.06K | 0.27% | 54 |
|
|
2021
Q3 | $1.7M | Buy |
11,935
+47
| +0.4% | +$6.91K | 0.29% | 51 |
|
|
2021
Q2 | $1.86M | Sell |
11,888
-73
| -0.6% | -$11.8K | 0.3% | 49 |
|
|
2021
Q1 | $1.86M | Sell |
11,961
-11
| -0.1% | -$1.7K | 0.35% | 46 |
|
|
2020
Q4 | $1.79M | Sell |
11,972
-91
| -0.8% | -$12.9K | 0.35% | 48 |
|
|
2020
Q3 | $1.59M | Sell |
12,063
-138
| -1% | -$18K | 0.36% | 53 |
|
|
2020
Q2 | $1.41M | Sell |
12,201
-1,102
| -8% | -$127K | 0.33% | 57 |
|
|
2020
Q1 | $1.31M | Buy |
13,303
+522
| +4% | +$68.4K | 0.37% | 55 |
|
|
2019
Q4 | $1.86M | Sell |
12,781
-12
| -0.1% | -$1.66K | 0.36% | 56 |
|
|
2019
Q3 | $1.71M | Buy |
12,793
+19
| +0.1% | +$2.45K | 0.35% | 60 |
|
|
2019
Q2 | $1.46M | Sell |
12,774
-69
| -0.5% | -$8.08K | 0.3% | 65 |
|
|
2019
Q1 | $1.59M | Buy |
12,843
+43
| +0.3% | +$4.89K | 0.32% | 63 |
|
|
2018
Q4 | $1.29M | Sell |
12,800
-324
| -2% | -$36.4K | 0.29% | 70 |
|
|
2018
Q3 | $1.68M | Buy |
13,124
+111
| +0.9% | +$13.2K | 0.32% | 65 |
|
|
2018
Q2 | $1.41M | Buy |
13,013
+146
| +1% | +$15.9K | 0.29% | 70 |
|
|
2018
Q1 | $1.36M | Sell |
12,867
-103
| -0.8% | -$12K | 0.31% | 67 |
|
|
2017
Q4 | $1.52M | Buy |
+12,970
| New | +$1.47M | 0.33% | 63 |
|
Other funds holding ZBH
VCM
VPM
Claret Asset Management's ZBH Position: Q1 2026 in Review
Claret Asset Management reduced its Zimmer Biomet (ZBH) stake by 0.06% in Q1 2026, selling an estimated $551 and leaving 10,839 shares worth $980K. The position accounts for 0.12% of the portfolio, ranked #80.
Claret Asset Management first reported a position in ZBH in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.86M in Q1 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Claret Asset Management held 10,839 shares of Zimmer Biomet worth $980K as of Q1 2026.
- Claret Asset Management sold 6 Zimmer Biomet shares in Q1 2026, an estimated $551.
- Zimmer Biomet made up 0.12% of Claret Asset Management's portfolio in Q1 2026, its #80 holding.
- Claret Asset Management first reported a position in Zimmer Biomet in Q4 2017 and has held it in 34 quarters since.
- Claret Asset Management's Zimmer Biomet position peaked at $1.86M in Q1 2021.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.